Inventor · disambiguated record
Johan Kajanus
Also filed as: KAJANUS JOHAN
4 granted patents·8 pending applications·8 citations·filing 2005–2022
66Inventor score
Files withASTRAZENECA AB12
Top patents by PatentIndex Score
12 records- 0179US9394291B2Benzoxazinone amides as mineralocorticoid receptor modulatorsASTRAZENECA AB·Filed 2015·Granted Jul 19, 2016·5 cites·5 claims
- 0273US7648985B2Oxabispidine compounds and their use in the treatment of cardiac arrhythmiasASTRAZENECA AB·Filed 2005·Granted Jan 19, 2010·3 cites·1 claims
- 0358US2025042882A1Certain 3-azabicyclo[3.1.0]hexanes as glp-1 receptor modulatorsASTRAZENECA AB·Filed 2022·Application pending·0 cites
- 0458US2025066338A1Certain 3-azabicyclo[3.1.0]hexanes as glp-1 receptor modulatorsASTRAZENECA AB·Filed 2022·Application pending·0 cites
- 0557US2009270383A1Novel Oxabispidine Compounds And Their Use In The Treatment Of Cardiac ArrhythmiasASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 0657US2024417393A1Certain 2,5-diazabicyclo[4.2.0]octanes as glp-1 receptor modulatorsASTRAZENECA AB·Filed 2022·Application pending·0 cites
- 0757US2025236627A1Certain octahydrofuro[3,4- b]pyrazines as glp-1 receptor modulatorsASTRAZENECA AB·Filed 2022·Application pending·0 cites
- 0856US2025115612A1Certain 2,5-diazabicyclo[4.2.0]octanes and octahydrofuro[3,4-b]pyrazines as glp-1 receptor modulatorsASTRAZENECA AB·Filed 2022·Application pending·0 cites
- 0956US2008015237A1New compounds i/418ASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 1056US2010298392A1Isoindoline Derivatives For The Treatment Of ArrhythmiasASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 1142US10017502B2Benzoxazinone amides as mineralocorticoid receptor modulatorsASTRAZENECA AB·Filed 2015·Granted Jul 10, 2018·0 cites·11 claims
- 1241US7928225B2Oxabispidine compounds for the treatment of cardiac arrhythmiasASTRAZENECA AB·Filed 2006·Granted Apr 19, 2011·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Johan Kajanus files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →